DOJ Joins Whistleblower Suit Against Drug Manufacturer

On February 1, 2011, the U.S. Department of Justice filed a motion indicating its intent to join in a whistleblower suit against Abbott Laboratories, Inc. This False Claims Act case was brought by whistleblowers inside Abbott Laboratories and accuses the company and the subsidiary of legally promoting off-label uses of the seizure drug Depakote for which it was reimbursed by the federal government. The allegations also include claims that Abbott illegally paid kickbacks to doctors to increase subscriptions which subsequently defrauded Medicare and Medicaid.

For more information see:  http://www.pharmalot.com/2011/02/feds-join-lawsuit-over-abbott-off-label-marketing/